馬ヘルスケア市場規模、シェア、成長分析：製品タイプ別、疾患タイプ別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025～2032年

馬ヘルスケア市場規模は2023年に37億9,000万米ドルとなり、予測期間（2025-2032年）のCAGRは7.0%で、2024年の40億6,000万米ドルから2032年には69億7,000万米ドルに成長する見通しです。

馬ヘルスケア市場は、研究開発イニシアチブの急増、馬の健康合併症の増加、馬をベースとした治療法の受け入れ拡大などを背景に、力強い成長を遂げています。人工知能（AI）のイントロダクションはこの分野に大きな影響を及ぼしており、この技術を馬の診療に取り入れることに注力する獣医学研究者の間で技術革新が促進されています。主要企業は、根強い課題に取り組み、タイムリーな健康評価を通じてヘルスケア管理を強化するため、こうした進歩を積極的に支援しています。この技術進化により、馬の早期疾病診断と個別化治療が強化されつつあります。馬ヘルスケアは、予防医療、疾病管理、跛行治療、繁殖医療、行動問題への対処を網羅し、最終的には馬の仲間の全体的な健康状態の改善、疾病の早期発見、長寿を促進します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

馬ヘルスケア市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 薬物
• ワクチン
• 医療用飼料添加物

馬ヘルスケア市場規模：疾患タイプ別& CAGR（2025-2032）

• 市場概要
• 馬インフルエンザ
• 馬ヘルペスウイルス
• 馬脳脊髄炎
• 馬ウエストナイルウイルス
• その他

馬ヘルスケア市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 動物病院
• 獣医クリニック
• 小売薬局
• オンライン薬局

馬ヘルスケア市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 動物病院
• 獣医クリニック
• その他

馬ヘルスケア市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Elanco Animal Health（USA）
• Bayer AG（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Dechra Pharmaceuticals PLC（UK）
• IDEXX Laboratories, Inc.（USA）
• Vetoquinol S.A.（France）
• Norbrook Laboratories Limited（UK）
• EQUINE PRODUCTS UK LTD（UK）
• KRKA（Slovenia）
• HIPRA（Spain）
• Luitpold Pharmaceuticals, Inc.（USA）
• Affymetrix Inc.（USA）
• Sanofi（France）
• Novartis Animal Health（Switzerland）
• Signostics（Australia）
• Merial（USA）

結論と提言

Equine Healthcare Market size was valued at USD 3.79 billion in 2023 and is poised to grow from USD 4.06 billion in 2024 to USD 6.97 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The equine healthcare market is experiencing robust growth, driven by a surge in research and development initiatives, a rise in equine health complications, and the increasing acceptance of equine-based therapies. The introduction of artificial intelligence (AI) is significantly impacting the sector, fostering innovation among veterinary researchers focused on integrating this technology into equine practices. Leading companies are actively supporting these advancements to tackle persistent challenges and enhance healthcare management through timely health assessments. This technological evolution is enhancing early disease diagnosis and personalized treatments for horses. Equine healthcare encompasses preventive care, illness management, lameness treatment, reproductive care, and addressing behavioral issues, ultimately promoting better overall health, early disease detection, and longevity for equine companions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Equine Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Equine Healthcare Market Segments Analysis

Global Equine Healthcare Market is segmented by Product Type, Disease Type, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Drugs, Vaccines and Medical Feed Additives. Based on Disease Type, the market is segmented into Equine Influenza, Equine Herpesvirus, Equine Encephalomyelitis, Equine West Nile Virus and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies and Online Pharmacies. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Equine Healthcare Market

The Equine Healthcare market is experiencing robust growth, fueled by the surging popularity of equine sports and recreational activities. Events such as horse racing, show jumping, and dressage necessitate the maintenance of healthy and well-cared-for horses, thereby driving demand for healthcare products and services. This heightened enthusiasm for equine activities has led to increased investments in vaccinations, nutritional supplements, and grooming essentials, all aimed at promoting the overall well-being of horses. As more individuals engage in these activities, the need for comprehensive equine healthcare solutions expands, highlighting the market's potential for continued development and innovation.

Restraints in the Equine Healthcare Market

The Equine Healthcare market is significantly hindered by the high costs associated with equine medical products and services. Veterinary care for horses, including surgeries, specialized therapies, and routine check-ups, can be prohibitively expensive for small facilities. Although advanced diagnostic tools and treatments may offer effective solutions, their financial implications can pose serious challenges. This financial burden is particularly pronounced in emerging economies where disposable incomes are limited, further restricting the market's growth potential. As a result, the steep costs of necessary equine healthcare services deter investment and accessibility, ultimately impacting the overall development of the industry.

Market Trends of the Equine Healthcare Market

The incorporation of telemedicine in equine healthcare is emerging as a significant market trend, revolutionizing how veterinary services are delivered to horse owners. As digital platforms gain traction, veterinarians can now conduct consultations, monitor recovery, and provide expert guidance remotely, enhancing accessibility for horse owners, especially in rural or remote areas where advanced care may be scarce. This shift not only improves the convenience and efficiency of veterinary services but also reduces the costs associated with transporting horses for routine check-ups and minor treatments. As a result, telemedicine is expected to play a pivotal role in shaping the future of equine healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Equine Healthcare Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Drugs
• Vaccines
• Medical Feed Additives

Global Equine Healthcare Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Equine Influenza
• Equine Herpesvirus
• Equine Encephalomyelitis
• Equine West Nile Virus
• Others

Global Equine Healthcare Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies

Global Equine Healthcare Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Others

Global Equine Healthcare Market Size & CAGR (2025-2032)

• North America (Product Type, Disease Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Disease Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EQUINE PRODUCTS UK LTD (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KRKA (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luitpold Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Animal Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signostics (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merial (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations